Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories.

ABSTRACT:

Objectives

To investigate the proportion of potentially relevant undisclosed financial ties between clinical practice guideline writers and pharmaceutical companies.

Design

Cross-sectional study of a stratified random sample of Australian guidelines and writers.

Setting

Guidelines available from Australia's National Health and Medical Research Council guideline database, 2012-2014, stratified across 10 health priority areas.

Population

402 authors of 33 guidelines, including up to four from each area, dependent on availability: arthritis/musculoskeletal (3); asthma (4); cancer (4); cardiovascular (4); diabetes (4); injury (3); kidney/urogenital (4); mental health (4); neurological (1); obesity (1). For guideline writers with no disclosures, or who disclosed no

SUBMITTER: Moynihan R 

PROVIDER: S-EPMC6377504 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature